ELF3 and cervical cancer: TCGA analyses demonstrated that high ELF3 expression levels were associated with HPV+ head and neck cancers regardless of the subsite, and co-occurring HIDDEN cell biomarkers were preliminarily associated with worse outcomes in cervical cancer.